Episode 10 of The Med Ad News Show Podcast concludes the three-part series of conversations with Thomas Sullivan, the president and founder of Rockpointe Corporation and the creator of the Policy and Medicine blog at www.policymed.com. In this episode, Mr. Sullivan reveals how he defines conflict of interest in continuing medical education and discusses the policies already in place within the CME industry to root it out.
In the final installment of a two-part series, Med Ad News Show hosts Steve Niles and Joshua Slatko are joined by John Castellani, the new President and CEO of the Pharmaceutical Research and Manufacturers of America, for an insightful discussion of the issues driving PhRMA's agenda today. Mr. Castellani addresses PhRMA's relationship with Washington as well as the pharmaceutical industry's relationship with its partners in academia. In addition, he gives his opinion on the pace of FDA's approval of new medicines and lays out his vision for PhRMA's future.
A silver lining may exist for the healthcare communications industry. John Kamp, executive director of the Coalition for Healthcare Communication, discusses why communications companies could see an upswing in business as a number of factors take shape. A competent, confident FDA has the potential to open a wider approval window, bringing many new products to market. Healthcare reform has the potential to bring in many new patients demanding information about available medicines.
John Kamp, executive director of the Coalition for Healthcare Communication, discusses what is yet to come from the Food and Drug Administration Amendments Act of 2007, including the growing importance of Risk Evaluation and Mitigation Strategies (REMS). In addition, Mr. Kamp details a host of hidden threats to healthcare communications coming from a variety of powerful institutions that are trying to throw pharmaceutical marketers out of organized medicine.
In Episode 13 of The Med Ad News Show, Editors Steve Niles and Joshua Slatko are joined by Biotechnology Industry Organization President and CEO James C. Greenwood to discuss President Obama's FY 2012 budget proposal, which Mr. Greenwood believes flies in the face of the President's own call for the United States to "win the future" and maintain the nation's leadership in research and technology. Mr.
In Episode 15 of The Med Ad News Show, Managing Editor Joshua Slatko is joined by Ilyssa Levins and Wayne Pines of the Center for Communications Compliance and Scott Cotherman, CEO, CAHG, the first healthcare advertising agency to become fully certified in regulatory compliance for advertising and promotion through the CCC. The group examines the pressure on pharma ad agencies to ensure regulatory compliance is a priority, as increasing government oversight is causing clients to ask agencies to demonstrate their strength and expertise in the subject. Ms.
Pharmaceutical sales forces throughout the industry are adopting closed-loop marketing (CLM) programs to gain real-time physician feedback from their product details. But effectively measuring and analyzing the flood of data CLM provides remains a considerable challenge. In Episode 7 of The Med Ad News Show Podcast, Dale Hagemeyer, a managing VP at Gartner Research, discusses the future of CLM and why the tactic has huge potential for success in today's changing sales environment.
Industry narrowly avoided an elimination of the marketing expense tax exemption in the healthcare reform bill. However, it's a popular idea in Washington that could rear its head again with potentially devastating effect for the healthcare communications industry. John Kamp, executive director of the Coalition for Healthcare Communication, explains why the threat continues to keep him up at night.
For decades, continuing medical education has been under attack, faced with charges of bias and conflict of interest when sponsored by commercial organizations. Episode 8 of The Med Ad News Show Podcast kicks off a three-part series of conversations with Thomas Sullivan, the president and founder of Rockpointe Corporation and the creator of the Policy and Medicine blog at www.policymed.com. In this episode, Mr. Sullivan discusses his efforts to give a voice to the CME industry's defenders.
In Episode 14 of The Med Ad News Show, James C. Greenwood, CEO and president of BIO, continues his conversation with Editors Steve Niles and Joshua Slatko to discuss the results of the organization's recent survey of industry and other life science thought leaders to suggest out-of-the-box big ideas to significantly enhance biotechnology's chances to succeed, and the efforts BIO will make to work with Congress in order to turn these big ideas into effective legislation. In addition, Mr.
- Biotechnology Companies
- Contract Manufacturing
- Drug Delivery
- Drug Discovery and Pipelines
- DTC Advertising
- Healthcare Agencies
- Japanese Pharma Companies
- Life Sciences Investment
- Medical Device Companies
- New Medical Devices
- New Medicines
- Nutraceuticals and Vitamin Supplements
- Personnel and Leadership
- Pharmaceutical Companies
- Specialty Pharmaceutical Companies
- Therapeutic Categories